vs
劲量控股（ENR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
劲量控股的季度营收约是Revvity的1.0倍（$778.9M vs $772.1M），Revvity净利率更高（12.7% vs -0.4%，领先13.2%），劲量控股同比增速更快（6.5% vs 5.9%），Revvity自由现金流更多（$161.8M vs $124.2M），过去两年Revvity的营收复合增速更高（9.0% vs 8.4%）
劲量控股是美国电池制造企业，也是全球规模最大的电池生产商之一，总部位于密苏里州克莱顿。旗下拥有劲量、雷特威、瓦尔塔、永备等多个电池品牌，2015年公司将原个人护理业务拆分，成立独立的Edgewell个人护理公司。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
ENR vs RVTY — 直观对比
营收规模更大
ENR
是对方的1.0倍
$772.1M
营收增速更快
ENR
高出0.6%
5.9%
净利率更高
RVTY
高出13.2%
-0.4%
自由现金流更多
RVTY
多$37.6M
$124.2M
两年增速更快
RVTY
近两年复合增速
8.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $778.9M | $772.1M |
| 净利润 | $-3.4M | $98.4M |
| 毛利率 | 32.9% | — |
| 营业利润率 | -0.6% | 14.5% |
| 净利率 | -0.4% | 12.7% |
| 营收同比 | 6.5% | 5.9% |
| 净利润同比 | -115.2% | 3.9% |
| 每股收益（稀释后） | — | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENRRVTY
| Q4 25 | $778.9M | $772.1M | ||
| Q3 25 | $832.8M | $698.9M | ||
| Q2 25 | $725.3M | $720.3M | ||
| Q1 25 | $662.9M | $664.8M | ||
| Q4 24 | $731.7M | $729.4M | ||
| Q3 24 | $805.7M | $684.0M | ||
| Q2 24 | $701.4M | $691.7M | ||
| Q1 24 | $663.3M | $649.9M |
净利润ENRRVTY
| Q4 25 | $-3.4M | $98.4M | ||
| Q3 25 | $34.9M | $46.7M | ||
| Q2 25 | $153.5M | $53.9M | ||
| Q1 25 | $28.3M | $42.2M | ||
| Q4 24 | $22.3M | $94.6M | ||
| Q3 24 | $47.6M | $94.4M | ||
| Q2 24 | $-43.8M | $55.4M | ||
| Q1 24 | $32.4M | $26.0M |
毛利率ENRRVTY
| Q4 25 | 32.9% | — | ||
| Q3 25 | 36.6% | 53.6% | ||
| Q2 25 | 55.1% | 54.5% | ||
| Q1 25 | 39.1% | 56.5% | ||
| Q4 24 | 36.8% | — | ||
| Q3 24 | 38.1% | 56.3% | ||
| Q2 24 | 39.5% | 55.7% | ||
| Q1 24 | 38.2% | 54.6% |
营业利润率ENRRVTY
| Q4 25 | -0.6% | 14.5% | ||
| Q3 25 | 6.4% | 11.7% | ||
| Q2 25 | 22.6% | 12.6% | ||
| Q1 25 | 5.5% | 10.9% | ||
| Q4 24 | 4.1% | 16.3% | ||
| Q3 24 | 7.4% | 14.3% | ||
| Q2 24 | -8.2% | 12.4% | ||
| Q1 24 | 6.4% | 6.8% |
净利率ENRRVTY
| Q4 25 | -0.4% | 12.7% | ||
| Q3 25 | 4.2% | 6.7% | ||
| Q2 25 | 21.2% | 7.5% | ||
| Q1 25 | 4.3% | 6.4% | ||
| Q4 24 | 3.0% | 13.0% | ||
| Q3 24 | 5.9% | 13.8% | ||
| Q2 24 | -6.2% | 8.0% | ||
| Q1 24 | 4.9% | 4.0% |
每股收益（稀释后）ENRRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $214.8M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $141.3M | $7.3B |
| 总资产 | $4.4B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENRRVTY
| Q4 25 | $214.8M | $919.9M | ||
| Q3 25 | $236.2M | $931.4M | ||
| Q2 25 | $171.1M | $991.8M | ||
| Q1 25 | $139.3M | $1.1B | ||
| Q4 24 | $195.9M | $1.2B | ||
| Q3 24 | $216.9M | $1.2B | ||
| Q2 24 | $146.7M | $2.0B | ||
| Q1 24 | $158.1M | $1.7B |
总债务ENRRVTY
| Q4 25 | — | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — | ||
| Q1 24 | $3.2B | — |
股东权益ENRRVTY
| Q4 25 | $141.3M | $7.3B | ||
| Q3 25 | $169.9M | $7.4B | ||
| Q2 25 | $183.2M | $7.6B | ||
| Q1 25 | $133.9M | $7.6B | ||
| Q4 24 | $140.6M | $7.7B | ||
| Q3 24 | $135.8M | $7.9B | ||
| Q2 24 | $123.4M | $7.9B | ||
| Q1 24 | $191.3M | $7.8B |
总资产ENRRVTY
| Q4 25 | $4.4B | $12.2B | ||
| Q3 25 | $4.6B | $12.1B | ||
| Q2 25 | $4.5B | $12.4B | ||
| Q1 25 | $4.2B | $12.4B | ||
| Q4 24 | $4.2B | $12.4B | ||
| Q3 24 | $4.3B | $12.8B | ||
| Q2 24 | $4.2B | $13.4B | ||
| Q1 24 | $4.3B | $13.4B |
负债/权益比ENRRVTY
| Q4 25 | — | — | ||
| Q3 25 | 20.28× | — | ||
| Q2 25 | 17.57× | — | ||
| Q1 25 | 23.56× | — | ||
| Q4 24 | 22.17× | — | ||
| Q3 24 | 23.51× | — | ||
| Q2 24 | 26.04× | — | ||
| Q1 24 | 16.86× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $149.5M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $124.2M | $161.8M |
| 自由现金流率自由现金流/营收 | 15.9% | 21.0% |
| 资本支出强度资本支出/营收 | 3.2% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $145.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流ENRRVTY
| Q4 25 | $149.5M | $182.0M | ||
| Q3 25 | $61.5M | $138.5M | ||
| Q2 25 | $21.4M | $134.3M | ||
| Q1 25 | $-12.8M | $128.2M | ||
| Q4 24 | $77.0M | $174.2M | ||
| Q3 24 | $168.9M | $147.9M | ||
| Q2 24 | $45.8M | $158.6M | ||
| Q1 24 | $36.8M | $147.6M |
自由现金流ENRRVTY
| Q4 25 | $124.2M | $161.8M | ||
| Q3 25 | $46.7M | $120.0M | ||
| Q2 25 | $7.9M | $115.5M | ||
| Q1 25 | $-33.8M | $112.2M | ||
| Q4 24 | $42.4M | $149.8M | ||
| Q3 24 | $141.5M | $125.6M | ||
| Q2 24 | $27.3M | $136.6M | ||
| Q1 24 | $10.3M | $129.7M |
自由现金流率ENRRVTY
| Q4 25 | 15.9% | 21.0% | ||
| Q3 25 | 5.6% | 17.2% | ||
| Q2 25 | 1.1% | 16.0% | ||
| Q1 25 | -5.1% | 16.9% | ||
| Q4 24 | 5.8% | 20.5% | ||
| Q3 24 | 17.6% | 18.4% | ||
| Q2 24 | 3.9% | 19.7% | ||
| Q1 24 | 1.6% | 20.0% |
资本支出强度ENRRVTY
| Q4 25 | 3.2% | 2.6% | ||
| Q3 25 | 1.8% | 2.6% | ||
| Q2 25 | 1.9% | 2.6% | ||
| Q1 25 | 3.2% | 2.4% | ||
| Q4 24 | 4.7% | 3.4% | ||
| Q3 24 | 3.4% | 3.3% | ||
| Q2 24 | 2.6% | 3.2% | ||
| Q1 24 | 4.0% | 2.7% |
现金转化率ENRRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 1.76× | 2.97× | ||
| Q2 25 | 0.14× | 2.49× | ||
| Q1 25 | -0.45× | 3.03× | ||
| Q4 24 | 3.45× | 1.84× | ||
| Q3 24 | 3.55× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 1.14× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENR
| Alkaline Batteries | $666.5M | 86% |
| Auto Care | $93.7M | 12% |
| Lights | $18.7M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
